News

Santé log3h
Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals
Genitourinary Tumor Study Ongoing with Active Screening and Enrollment. MILAN and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-o ...
Santé log3h
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
Alvotech and Advanz Pharma have previously entered into partnership agreements for biosimilar candidates to more than ten reference biologics. The companies expect to launch their first biosimilars in ...
Santé log5h
INCONTINENCE : « Écouter directement les nerfs » pour supprimer les urgences
Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les ...
Santé log5h
ÉVÉNEMENT CARDIOVASCULAIRE : L'association d'hypolipémiants qui pourrait anéantir le risque
Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les ...
Santé log6h
ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
The randomized, placebo-controlled trial is evaluating the safety and efficacy of three dose levels of RPN-001 in men with low testosterone and impaired semen quality. The study plans to enroll ...
Santé log6h
UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss
Rinri Therapeutics, a world leading company focused on transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, is pleased to announce the approval of its Clinical Trial ...
Santé log6h
CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité
À la date de résiliation de ce contrat, les moyens suivants figuraient au compte de liquidité : ...
Santé log9h
Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock
This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...
Santé log9h
Rakovina Therapeutics Announces Intention to Amend Debentures and Warrants
VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “ Company ”) announces that it will apply to the TSX Venture Exchange (the “ Exchange ”) to ...
Santé log12h
Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure
Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...
Santé log12h
COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders
As a result, shareholders were not asked to approve the unallocated entitlements under the Company’s long-term incentive plan at the AGSM. For full voting details, please see the report of voting ...
Santé log15h
The Real Jerry Maguire Meets Prof. Mike Chan of European Wellness Biomedical Group to Discuss Sports Injuries and Concussion Recovery
The man who inspired the multiple award-winning movie “Jerry Maguire” meets the pioneering stem cell scientist who is ...